2,416 Shares in CME Group Inc. $CME Purchased by one8zero8 LLC

one8zero8 LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 2,416 shares of the financial services provider’s stock, valued at approximately $533,000.

Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of CME Group in the 2nd quarter valued at approximately $6,749,965,000. Norges Bank acquired a new stake in shares of CME Group during the fourth quarter worth $1,523,241,000. Bank of New York Mellon Corp purchased a new position in CME Group in the 2nd quarter valued at $867,313,000. Alphabet Inc. acquired a new position in CME Group in the 2nd quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in CME Group during the 2nd quarter worth $629,771,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Down 1.7%

CME opened at $266.94 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $95.99 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 3.16 and a beta of 0.23. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The business’s fifty day moving average is $250.89 and its two-hundred day moving average is $279.81.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the business posted $2.96 earnings per share. Analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is 44.11%.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 325 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on CME. Bank of America raised their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Barclays cut their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a report on Thursday, July 9th. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research report on Thursday, June 18th. Finally, The Goldman Sachs Group lowered their price objective on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $288.56.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.